
NextPlat Corp. (NASDAQ:NXPL – Free Report) – Investment analysts at Litchfield Hills Research issued their Q3 2026 earnings estimates for shares of NextPlat in a research note issued to investors on Monday, August 17th. Litchfield Hills Research analyst T. O’neill anticipates that the company will post earnings per share of ($0.46) for the quarter. Litchfield Hills Research currently has a “Buy” rating and a $11.00 target price on the stock. The consensus estimate for NextPlat’s current full-year earnings is ($0.55) per share. Litchfield Hills Research also issued estimates for NextPlat’s FY2026 earnings at ($0.85) EPS.
NextPlat (NASDAQ:NXPL – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.16. NextPlat had a negative return on equity of 54.66% and a negative net margin of 20.38%.The business had revenue of $11.88 million during the quarter, compared to the consensus estimate of $11.00 million.
Check Out Our Latest Research Report on NXPL
NextPlat Price Performance
Shares of NASDAQ:NXPL opened at $8.53 on Thursday. The company has a quick ratio of 2.12, a current ratio of 2.29 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $23.12 million, a PE ratio of -2.32 and a beta of 1.83. NextPlat has a twelve month low of $3.38 and a twelve month high of $11.10. The company has a 50-day moving average price of $6.55 and a two-hundred day moving average price of $5.99.
Institutional Trading of NextPlat
An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new position in NextPlat Corp. (NASDAQ:NXPL – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat at the end of the most recent reporting period. 1.30% of the stock is owned by hedge funds and other institutional investors.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
See Also
- Five stocks we like better than NextPlat
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
